Natus Medical Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2015. For the quarter, the company reported revenue was $99,951,000 compared with $94,010,000 for the same period last year. Income from operations was $10,049,000 compared with $13,644,000 for the same period last year. Income before tax was $10,188,000 compared with $14,140,000 for the same period last year. Net income was $8,545,000 or $0.26 diluted per share compared with $10,440,000 or $0.32 diluted per share for the same period last year. Non-GAAP income before provision for income tax was $20,620,000 compared with $17,500,000 for the same period last year. Non-GAAP net income was $17,033,000 or $0.51 diluted per share compared with $13,102,000 or $0.40 diluted per share for the same period last year. Non-GAAP Operating profit was $20,337,000 compared with $17,004,000 for the same period last year.

For the full year, the company reported revenue was $375,865,000 compared with $355,834,000 for the same period last year. Income from operations was $53,473,000 compared with $45,847,000 for the same period last year. Income before tax was $52,410,000 compared with $46,008,000 for the same period last year. Net income was $37,925,000 or $1.14 diluted per share compared with $32,478,000 or $1.00 diluted per share for the same period last year. Non-GAAP income before provision for income tax was $70,413,000 compared with $57,333,000 for the same period last year. Non-GAAP net income was $51,408,000 or $1.55 diluted per share compared with $40,940,000 or $1.26 diluted per share for the same period last year. Non-GAAP Operating profit was $71,332,000 compared with $57,172,000 for the same period last year.

For the first quarter of 2016, the company provided revenue guidance of $96.5 million to $97.5 million and guided non-GAAP earnings per share of $0.34 to $0.35.

For the full year 2016, the company provided revenue guidance of $445.0 million to $450.0 million and guided non-GAAP earnings per share of $1.84 to $1.88. The company remain committed to driving towards 2016 goal of a 20% non-GAAP operating margin. Guidance for 2016 implies a tax rate of approximately 30%.